Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure

Karen E. Joynt, Wendy A. Gattis, Vic Hasselblad, Sergey Y. Fuzaylov, Victor L. Serebruany, Paul A. Gurbel, Laura H. Gaulden, G. Michael Felker, David J. Whellan, Christopher M. O'Connor

Research output: Contribution to journalArticle

Abstract

C-reactive protein (CRP) levels were measured in a cohort of 96 outpatients with heart failure. Baseline angiotensin-converting enzyme inhibitor plus β-blocker use were associated with lower levels of CRP; no relation was found between CRP levels and aspirin or statin use.

Original languageEnglish (US)
Pages (from-to)783-785
Number of pages3
JournalAmerican Journal of Cardiology
Volume93
Issue number6
DOIs
StatePublished - Mar 15 2004

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Joynt, K. E., Gattis, W. A., Hasselblad, V., Fuzaylov, S. Y., Serebruany, V. L., Gurbel, P. A., Gaulden, L. H., Felker, G. M., Whellan, D. J., & O'Connor, C. M. (2004). Effect of angiotensin-converting enzyme inhibitors, beta blockers, statins, and aspirin on C-reactive protein levels in outpatients with heart failure. American Journal of Cardiology, 93(6), 783-785. https://doi.org/10.1016/j.amjcard.2003.12.010